These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1427 related articles for article (PubMed ID: 34347278)
1. Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report. Iguchi T; Umeda H; Kojima M; Kanno Y; Tanaka Y; Kinoshita N; Sato D Drug Saf; 2021 Nov; 44(11):1209-1214. PubMed ID: 34347278 [TBL] [Abstract][Full Text] [Related]
2. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020. ; MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(2):46-51. PubMed ID: 33444297 [TBL] [Abstract][Full Text] [Related]
3. Adverse Events of COVID-19 Vaccines in the United States: Temporal and Spatial Analysis. Li Y; Li J; Dang Y; Chen Y; Tao C JMIR Public Health Surveill; 2024 Jul; 10():e51007. PubMed ID: 39008362 [TBL] [Abstract][Full Text] [Related]
4. Revaccination outcomes among adolescents and adults with suspected hypersensitivity reactions following COVID-19 vaccination: A Canadian immunization research network study. Fitzpatrick T; Yamoah P; Lacuesta G; Sadarangani M; Cook V; Pourshahnazari P; Kalicinsky C; Upton JEM; Cameron SB; Zaborniak K; Kanani A; Lam G; Burton C; Constantinescu C; Pernica JM; Abdurrahman Z; Betschel S; Drolet JP; De Serres G; Quach C; Des Roches A; Chapdelaine H; Salvadori MI; Carignan A; McConnell A; Pham-Huy A; Buchan CA; Cowan J; Hildebrand K; Top KA; Vaccine; 2024 Oct; 42(24):126078. PubMed ID: 38910092 [TBL] [Abstract][Full Text] [Related]
5. Imprecision in adverse event reports following immunization against HPV in Japan and COVID-19 in the USA, UK, and Japan-and the effects of vaccine hesitancy and government policy. Inokuma Y; Kneller R Eur J Clin Pharmacol; 2023 Feb; 79(2):269-278. PubMed ID: 36527455 [TBL] [Abstract][Full Text] [Related]
6. COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says. Chen G; Li X; Sun M; Zhou Y; Yin M; Zhao B; Li X Front Immunol; 2021; 12():669010. PubMed ID: 34093567 [TBL] [Abstract][Full Text] [Related]
7. COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol. Patel GB; Chhiba KD; Chen MM; Guo A; Watts MM; Cullen J; Bochner BS; Grammer LC; Greenberger PA; Saltoun CA; Stevens WW; Kuang FL; Peters AT Allergy Asthma Proc; 2021 Nov; 42(6):515-521. PubMed ID: 34871159 [No Abstract] [Full Text] [Related]
8. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021. Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735 [TBL] [Abstract][Full Text] [Related]
9. First Month of COVID-19 Vaccine Safety Monitoring - United States, December 14, 2020-January 13, 2021. Gee J; Marquez P; Su J; Calvert GM; Liu R; Myers T; Nair N; Martin S; Clark T; Markowitz L; Lindsey N; Zhang B; Licata C; Jazwa A; Sotir M; Shimabukuro T MMWR Morb Mortal Wkly Rep; 2021 Feb; 70(8):283-288. PubMed ID: 33630816 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk. Shavit R; Maoz-Segal R; Iancovici-Kidon M; Offengenden I; Haj Yahia S; Machnes Maayan D; Lifshitz-Tunitsky Y; Niznik S; Frizinsky S; Deutch M; Elbaz E; Genaim H; Rahav G; Levy I; Belkin A; Regev-Yochay G; Afek A; Agmon-Levin N JAMA Netw Open; 2021 Aug; 4(8):e2122255. PubMed ID: 34463744 [TBL] [Abstract][Full Text] [Related]
12. Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands. Kant A; Jansen J; van Balveren L; van Hunsel F Drug Saf; 2022 Apr; 45(4):319-331. PubMed ID: 35314943 [TBL] [Abstract][Full Text] [Related]
13. Anaphylaxis to SARS-CoV-2 Vaccines in the Setting of a Nationwide Passive Epidemiological Surveillance Program. Toledo-Salinas C; Scheffler-Mendoza SC; Castano-Jaramillo LM; Ortega-Martell JA; Del Rio-Navarro BE; Santibáñez-Copado AM; Díaz-Ortega JL; Baptista-Rosas R; Sánchez-Novoa P; García-Grimshaw M; Valdés-Ferrer SI; Reyes-Terán G; Mendoza-Hernández DA J Clin Immunol; 2022 Nov; 42(8):1593-1599. PubMed ID: 35976470 [TBL] [Abstract][Full Text] [Related]
14. Pediatric anaphylactic adverse events following immunization in Victoria, Australia from 2007 to 2013. Cheng DR; Perrett KP; Choo S; Danchin M; Buttery JP; Crawford NW Vaccine; 2015 Mar; 33(13):1602-7. PubMed ID: 25698493 [TBL] [Abstract][Full Text] [Related]
15. Low Rates of Urologic Side Effects Following Coronavirus Disease Vaccination: An Analysis of the Food and Drug Administration Vaccine Adverse Event Reporting System. Zhao H; Souders C; Carmel M; Anger JT Urology; 2021 Jul; 153():11-13. PubMed ID: 33864857 [TBL] [Abstract][Full Text] [Related]
16. Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis. Chu DK; Abrams EM; Golden DBK; Blumenthal KG; Wolfson AR; Stone CA; Krantz MS; Shaker M; Greenhawt M JAMA Intern Med; 2022 Apr; 182(4):376-385. PubMed ID: 35188528 [TBL] [Abstract][Full Text] [Related]
17. Reporting of Allergic Reactions During Pfizer-BioNTech BNTT162B2 Vaccination in Israel. Anis E; Preis SA; Cedar N; Tal Y; Hershkowitz I; Hershko AY J Allergy Clin Immunol Pract; 2022 Nov; 10(11):2969-2976. PubMed ID: 35872216 [TBL] [Abstract][Full Text] [Related]
18. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336 [TBL] [Abstract][Full Text] [Related]
19. The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021. Deng L; Glover C; Dymock M; Pillsbury A; Marsh JA; Quinn HE; Leeb A; Cashman P; Snelling TL; Wood N; Macartney K Med J Aust; 2022 Aug; 217(4):195-202. PubMed ID: 35781813 [TBL] [Abstract][Full Text] [Related]
20. Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study. Mascolo A; di Mauro G; Fraenza F; Gaio M; Zinzi A; Pentella C; Rossi F; Capuano A; Sportiello L Front Immunol; 2022; 13():965171. PubMed ID: 36263025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]